Introduzione

Questa pagina fornisce un'analisi completa dello storico delle operazioni di insider trading note di Lindsey Rolfe. Gli insider sono funzionari, direttori o investitori importanti di una società. In generale, è illegale per gli insider effettuare operazioni di compravendita nelle loro aziende sulla base di informazioni materiali non pubbliche. Ciò non significa che sia illegale per loro effettuare qualsiasi operazioni di trading nelle proprie aziende. Tuttavia, devono segnalare tutte le operazioni alla SEC tramite un modulo 4. Nonostante queste restrizioni, la ricerca accademica suggerisce che gli insider, in generale, tendono a sovraperformare il mercato nelle proprie società.

Redditività media delle transazioni

La redditività media delle transazioni è il rendimento medio di tutti gli acquisti effettuati sul mercato aperto dagli insider negli ultimi tre anni. Pe calcolarla, esaminiamo tutti gli acquisti non pianificati effettuati dall'insider sul mercato aperto, escludendo tutte le operazioni che sono state parte di un piano di trading 10b5-1. Calcoliamo quindi la performance media di queste operazioni nell'arco di 3, 6 e 12 mesi e facciamo la media di ciascuna di queste durate per generare un indicatore di performance finale per ogni operazione. Infine, facciamo la media di tutti gli indicatori di performance per calcolare un indicatore di performance per l'insider. Questo elenco comprende solo gli insider che hanno effettuato almeno tre operazioni negli ultimi due anni.

Se la redditività delle operazioni di questo insider è "N/D", l'insider non ha effettuato acquisti sul mercato aperto negli ultimi tre anni, oppure le operazioni effettuate sono troppo recenti per poter calcolare un indicatore di performance affidabile.

Frequenza di aggiornamento: giornaliera

Vedi l'elenco degli insider trader più redditizi

Società con posizioni di insider dichiarate

I depositi SEC indicano che Lindsey Rolfe ha dichiarato partecipazioni o transazioni nelle seguenti società:

Titolo Ruolo Ultime partecipazioni dichiarate
US:CLVS / Clovis Oncology Inc See Remarks 113.691
US:BCEL / Atreca, Inc. Director 12.000
Come interpretare i grafici

I grafici seguenti mostrano l'andamento dei titoli dopo ogni operazione di mercato aperto non pianificata effettuata da Lindsey Rolfe. Per operazioni non pianificate si intendono operazioni non effettuate nell'ambito di un piano di trading 10b5-1. La performance dei titoli è rappresentata come variazione percentuale cumulativa del prezzo delle azioni. Ad esempio, se un'operazione di insider è stata effettuata il 1° gennaio 2019, il grafico mostrerà la variazione percentuale giornaliera del titolo fino ad oggi. Se il prezzo dell'azione passasse da 10 a 15 dollari durante questo periodo, la variazione percentuale cumulativa del prezzo dell'azione sarebbe del 50%. Una variazione di prezzo da 10 a 20 dollari sarebbe del 100%, mentre una variazione di prezzo da 10 a 5 dollari sarebbe del -50%.

In definitiva, cerchiamo di determinare la correlazione tra le operazioni dell'insider e i rendimenti in eccesso (positivi o negativi) del prezzo dell'azione, al fine di capire se l'insider sta programmando le proprie operazioni per trarre profitto da informazioni privilegiate. Immaginiamo che un insider stia facendo questo. In questa situazione, ci aspetteremmo (a) rendimenti positivi dopo gli acquisti, oppure (b) rendimenti negativi dopo le vendite. Nel caso (a), il grafico ACQUISTO mostrerebbe una serie di curve ascendenti, indicando rendimenti positivi dopo ogni operazione di acquisto. Nel caso (b), il grafico VENDITA mostrerebbe una serie di curve inclinate verso il basso, indicando rendimenti negativi dopo ogni operazione di vendita.

Tuttavia, questo non è sufficiente per trarre conclusioni. Se, ad esempio, il prezzo delle azioni della società è aumentato in maniera non ciclica per molti anni, allora ci aspetteremmo che tutti i grafici post-acquisto abbiano una pendenza rivolta verso l'alto. Allo stesso modo, ribassi non ciclici per molti anni darebbero luogo a grafici post-negoziazione rivolti verso il basso. Nessuno di questi grafici suggerisce un'attività di insider trading.

L'indicatore più forte sarebbe una situazione in cui il prezzo delle azioni fosse estremamente ciclico e vi fossero segnali positivi nel grafico ACQUISTO e curve negative nel grafico VENDITA. Questa situazione suggerirebbe che l'insider sta programmando le operazioni di trading per trarne un vantaggio finanziario.

Storico delle operazioni degli insider

Questa tabella mostra l'elenco completo delle operazioni effettuate da Lindsey Rolfe come comunicato alla Securities Exchange Commission (SEC).

Data di deposito Data della transazione Modulo Ticker Titolo Codice 10b5-1 Azioni Azioni rimanenti Variazione
percentuale
Prezzo
dell'azione
Valore
della transazione
Valore
rimanente
2022-11-03 2022-11-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2.353 113.691 -2,03 0,98 -2.313 111.747
2022-11-03 2022-11-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1.908 111.419 -1,68 0,98 -1.875 109.514
2022-11-03 2022-11-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 4.625 116.044 4,15
2022-11-03 2022-11-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3.749 113.327 3,42
2022-09-06 2022-09-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2.545 109.578 -2,27 1,20 -3.054 131.494
2022-09-06 2022-09-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 5.063 112.123 4,73
2022-08-03 2022-08-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2.391 107.060 -2,18 1,46 -3.493 156.404
2022-08-03 2022-08-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1.939 104.826 -1,82 1,46 -2.833 153.140
2022-08-03 2022-08-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 4.625 109.451 4,41
2022-08-03 2022-08-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3.749 106.765 3,64
2022-06-03 2022-06-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2.650 103.016 -2,51 0,64 -1.703 66.188
2022-06-03 2022-06-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 5.062 105.666 5,03
2022-05-03 2022-05-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2.348 100.604 -2,28 1,97 -4.625 198.170
2022-05-03 2022-05-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1.904 98.327 -1,90 1,97 -3.750 193.685
2022-05-03 2022-05-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -4.625 32.375 -12,50
2022-05-03 2022-05-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -3.749 11.248 -25,00
2022-05-03 2022-05-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 4.625 102.952 4,70
2022-05-03 2022-05-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3.749 100.231 3,89
2022-03-03 2022-03-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -10.585 96.482 -9,89 1,87 -19.752 180.035
2022-03-03 2022-03-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -360 86.817 -0,41 1,87 -672 162.001
2022-03-03 2022-03-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise 688 0 -100,00
2022-03-03 2022-03-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise 20.250 60.750 50,00
2022-03-03 2022-03-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
A - Award 81.000 81.000
2022-03-03 2022-03-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 20.250 107.067 23,32
2022-03-03 2022-03-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 688 87.177 0,80
2022-02-03 2022-02-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2.493 86.489 -2,80 1,94 -4.836 167.763
2022-02-03 2022-02-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2.021 84.357 -2,34 1,94 -3.920 163.619
2022-02-03 2022-02-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -4.625 37.000 -11,11
2022-02-03 2022-02-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -3.750 14.997 -20,00
2022-02-03 2022-02-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 4.625 88.982 5,48
2022-02-03 2022-02-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3.750 86.378 4,54
2021-12-03 2021-12-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -346 82.628 -0,42 3,00 -1.038 247.884
2021-12-03 2021-12-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -687 688 -49,96
2021-12-03 2021-12-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 687 82.974 0,83
2021-11-03 2021-11-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2.325 82.287 -2,75 4,55 -10.579 374.406
2021-11-03 2021-11-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1.884 79.987 -2,30 4,55 -8.572 363.941
2021-11-03 2021-11-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -4.625 41.625 -10,00
2021-11-03 2021-11-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -3.749 18.747 -16,67
2021-11-03 2021-11-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 4.625 84.612 5,78
2021-11-03 2021-11-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3.749 81.871 4,80
2021-09-03 2021-09-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -347 78.122 -0,44 4,89 -1.697 382.017
2021-09-03 2021-09-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -688 1.375 -33,35
2021-09-03 2021-09-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 688 78.469 0,88
2021-08-03 2021-08-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2.317 77.781 -2,89 4,82 -11.168 374.904
2021-08-03 2021-08-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1.878 75.473 -2,43 4,82 -9.052 363.780
2021-08-03 2021-08-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -4.625 46.250 -9,09
2021-08-03 2021-08-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -3.749 22.496 -14,28
2021-08-03 2021-08-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 4.625 80.098 6,13
2021-08-03 2021-08-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3.749 77.351 5,09
2021-06-11 2021-06-09 4 BCEL Atreca, Inc.
Stock Option (right to buy)
A - Award 12.000 12.000
2021-06-03 2021-06-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -322 73.602 -0,44 5,63 -1.813 414.379
2021-06-03 2021-06-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise 687 2.063 49,93
2021-06-03 2021-06-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 687 73.924 0,94
2021-05-04 2021-05-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2.486 73.237 -3,28 5,54 -13.772 405.733
2021-05-04 2021-05-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2.015 71.098 -2,76 5,54 -11.163 393.883
2021-05-04 2021-05-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -4.625 50.875 -8,33
2021-05-04 2021-05-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -3.749 26.245 -12,50
2021-05-04 2021-05-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 4.625 75.723 6,51
2021-05-04 2021-05-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3.749 73.113 5,40
2021-03-03 2021-03-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -346 69.364 -0,50 6,29 -2.176 436.300
2021-03-03 2021-03-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -315 69.022 -0,45 6,29 -1.981 434.148
2021-03-03 2021-03-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise 688 2.750 33,37
2021-03-03 2021-03-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise 625 0 -100,00
2021-03-03 2021-03-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
A - Award 81.000 81.000
2021-03-03 2021-03-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 688 69.710 1,00
2021-03-03 2021-03-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 625 69.337 0,91
2021-02-03 2021-02-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -9.822 68.712 -12,51 7,97 -78.281 547.635
2021-02-03 2021-02-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1.991 60.034 -3,21 7,97 -15.868 478.471
2021-02-03 2021-02-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -18.500 55.500 -25,00
2021-02-03 2021-02-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -3.750 29.994 -11,11
2021-02-03 2021-02-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 18.500 78.534 30,82
2021-02-03 2021-02-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3.750 62.025 6,44
2020-12-23 2020-12-21 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -3.438 0 -100,00
2020-12-23 2020-12-21 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1.728 58.275 -2,88 5,68 -9.815 331.002
2020-12-23 2020-12-21 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3.438 60.003 6,08
2020-12-16 2020-12-15 4 CLVS Clovis Oncology, Inc.
Employee Stock Option (right to buy)
M - Exercise -17.241 0 -100,00
2020-12-16 2020-12-15 4 CLVS Clovis Oncology, Inc.
Common Stock
F - Taxes -14.153 56.565 -20,01 5,11 -72.322 289.047
2020-12-16 2020-12-15 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 17.241 70.718 32,24 3,28 56.550 231.955
2020-12-07 2020-12-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -687 3.438 -16,65
2020-12-07 2020-12-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -625 625 -50,00
2020-12-07 2020-12-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -346 53.477 -0,64 4,89 -1.692 261.503
2020-12-07 2020-12-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 687 53.823 1,29
2020-12-07 2020-12-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -315 53.136 -0,59 4,89 -1.540 259.835
2020-12-07 2020-12-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 625 53.451 1,18
2020-11-05 2020-11-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -3.749 33.744 -10,00
2020-11-05 2020-11-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1.920 52.826 -3,51 4,93 -9.466 260.432
2020-11-05 2020-11-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3.749 54.746 7,35
2020-09-23 2020-09-21 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -3.437 3.438 -49,99
2020-09-23 2020-09-21 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1.726 50.997 -3,27 6,85 -11.823 349.329
2020-09-23 2020-09-21 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -21 52.723 -0,04 6,86 -144 361.680
2020-09-23 2020-09-21 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3.437 52.744 6,97
2020-09-08 2020-09-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -688 4.125 -14,29
2020-09-08 2020-09-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -625 1.250 -33,33
2020-09-08 2020-09-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -329 49.307 -0,66 5,30 -1.744 261.327
2020-09-08 2020-09-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 688 49.636 1,41
2020-09-08 2020-09-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -299 48.948 -0,61 5,30 -1.585 259.424
2020-09-08 2020-09-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 625 49.247 1,29
2020-08-05 2020-08-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -3.749 37.493 -9,09
2020-08-05 2020-08-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1.899 48.622 -3,76 5,92 -11.242 287.842
2020-08-05 2020-08-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3.749 50.521 8,02
2020-06-23 2020-06-22 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -3.438 6.875 -33,34
2020-06-23 2020-06-22 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1.728 46.772 -3,56 6,74 -11.647 315.243
2020-06-23 2020-06-22 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3.438 48.500 7,63
2020-06-15 2020-06-10 4 BCEL Atreca, Inc.
Stock Option (right to buy)
A - Award 12.000 12.000
2020-06-05 2020-06-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -687 4.813 -12,49
2020-06-05 2020-06-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -625 1.875 -25,00
2020-06-05 2020-06-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -356 45.062 -0,78 7,03 -2.503 316.786
2020-06-05 2020-06-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 687 45.418 1,54
2020-06-05 2020-06-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -324 44.731 -0,72 7,03 -2.278 314.459
2020-06-05 2020-06-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 625 45.055 1,41
2020-05-07 2020-05-05 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -3.749 41.242 -8,33
2020-05-07 2020-05-05 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1.677 44.430 -3,64 8,10 -13.584 359.883
2020-05-07 2020-05-05 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3.749 46.107 8,85
2020-04-08 2020-04-06 4 CLVS Clovis Oncology, Inc.
Employee Stock Option (right to buy)
M - Exercise -23.034 0 -100,00
2020-04-08 2020-04-06 4 CLVS Clovis Oncology, Inc.
Common Stock
F - Taxes -16.733 42.358 -28,32 6,80 -113.784 288.034
2020-04-08 2020-04-06 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 23.034 59.091 63,88 3,08 70.945 182.000
2020-03-23 2020-03-20 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -3.437 10.313 -25,00
2020-03-23 2020-03-20 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1.728 36.057 -4,57 4,60 -7.949 165.862
2020-03-23 2020-03-20 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3.437 37.785 10,01
2020-03-05 2020-03-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -688 5.500 -11,12
2020-03-05 2020-03-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -625 2.500 -20,00
2020-03-05 2020-03-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -360 34.348 -1,04 7,20 -2.592 247.306
2020-03-05 2020-03-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 688 34.708 2,02
2020-03-05 2020-03-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -327 34.020 -0,95 7,20 -2.354 244.944
2020-03-05 2020-03-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 625 34.347 1,85
2020-02-06 2020-02-04 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -14.997 44.991 -25,00
2020-02-06 2020-02-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -7.503 33.722 -18,20 8,41 -63.100 283.602
2020-02-06 2020-02-04 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 14.997 41.225 57,18
2020-01-31 2020-01-31 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
A - Award 74.000 74.000
2019-12-26 2019-12-20 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -3.438 13.750 -20,00
2019-12-26 2019-12-20 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1.729 26.228 -6,18 11,30 -19.538 296.376
2019-12-26 2019-12-20 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3.438 27.957 14,02
2019-12-05 2019-12-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -687 6.188 -9,99
2019-12-05 2019-12-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -625 3.125 -16,67
2019-12-05 2019-12-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -353 24.519 -1,42 14,61 -5.157 358.223
2019-12-05 2019-12-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 687 24.872 2,84
2019-12-05 2019-12-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -321 24.185 -1,31 14,59 -4.683 352.859
2019-12-05 2019-12-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 625 24.506 2,62
2019-09-24 2019-09-20 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -3.437 17.188 -16,66
2019-09-24 2019-09-20 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1.744 23.881 -6,81 4,80 -8.371 114.629
2019-09-24 2019-09-20 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3.437 25.625 15,49
2019-09-06 2019-09-04 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -688 6.875 -9,10
2019-09-06 2019-09-04 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -625 3.750 -14,29
2019-09-06 2019-09-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -375 22.188 -1,66 5,21 -1.954 115.599
2019-09-06 2019-09-04 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 688 22.563 3,15
2019-09-06 2019-09-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -341 21.875 -1,53 5,21 -1.777 113.969
2019-09-06 2019-09-04 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 625 22.216 2,89
2019-08-22 2019-08-22 4 BCEL Atreca, Inc.
Stock Option (right to buy)
A - Award 24.000 24.000
2019-06-24 2019-06-20 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -3.438 20.625 -14,29
2019-06-24 2019-06-20 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1.728 21.591 -7,41 14,70 -25.402 317.388
2019-06-24 2019-06-20 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3.438 23.319 17,29
2019-06-06 2019-06-04 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -687 7.563 -8,33
2019-06-06 2019-06-04 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -625 4.375 -12,50
2019-06-06 2019-06-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -343 19.881 -1,70 15,07 -5.169 299.607
2019-06-06 2019-06-04 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 687 20.224 3,52
2019-06-06 2019-06-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -312 19.537 -1,57 15,07 -4.702 294.423
2019-06-06 2019-06-04 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 625 19.849 3,25
2019-03-21 2019-03-20 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -3.437 24.063 -12,50
2019-03-21 2019-03-20 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1.729 19.224 -8,25 26,13 -45.179 502.323
2019-03-21 2019-03-20 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3.437 20.953 19,62
2019-03-06 2019-03-05 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -2.750 8.250 -25,00
2019-03-06 2019-03-05 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -625 5.000 -11,11
2019-03-06 2019-03-05 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1.410 17.516 -7,45 29,29 -41.299 513.044
2019-03-06 2019-03-05 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 2.750 18.926 17,00
2019-03-06 2019-03-05 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -321 16.176 -1,95 29,29 -9.402 473.795
2019-03-06 2019-03-05 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 625 16.497 3,94
2019-02-04 2019-02-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
A - Award 59.988 59.988
2019-02-04 2019-02-01 4 CLVS Clovis Oncology, Inc.
Stock Option (right to buy)
A - Award 19.996 19.996
2018-12-26 2018-12-20 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -3.438 27.500 -11,11
2018-12-26 2018-12-20 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1.728 15.872 -9,82 17,72 -30.620 281.252
2018-12-26 2018-12-20 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3.438 17.600 24,28
2018-12-06 2018-12-04 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -625 5.625 -10,00
2018-12-06 2018-12-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -284 14.162 -1,97 21,23 -6.029 300.659
2018-12-06 2018-12-04 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 625 14.446 4,52
2018-09-24 2018-09-20 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -3.437 30.938 -10,00
2018-09-24 2018-09-20 4 CLVS Clovis Oncology, Inc.
Common Stock
F - Taxes -1.728 13.821 -11,11 32,21 -55.659 445.174
2018-09-24 2018-09-20 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3.437 15.549 28,38
2018-09-07 2018-09-05 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -625 6.250 -9,09
2018-09-07 2018-09-05 4 CLVS Clovis Oncology, Inc.
Common Stock
F - Taxes -321 12.112 -2,58 35,75 -11.476 433.004
2018-09-07 2018-09-05 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 625 12.433 5,29
2018-06-21 2018-06-20 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -3.438 34.375 -9,09
2018-06-21 2018-06-20 4 CLVS Clovis Oncology, Inc.
Common Stock
F - Taxes -1.728 11.808 -12,77 45,75 -79.056 540.216
2018-06-21 2018-06-20 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3.438 13.536 34,05
2018-06-08 2018-06-06 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -625 6.875 -8,33
2018-06-08 2018-06-06 4 CLVS Clovis Oncology, Inc.
Common Stock
F - Taxes -316 10.098 -3,03 47,70 -15.073 481.675
2018-06-08 2018-06-06 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 625 10.414 6,38
2018-03-21 2018-03-20 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -3.437 37.813 -8,33
2018-03-21 2018-03-20 4 CLVS Clovis Oncology, Inc.
Common Stock
F - Taxes -1.728 9.789 -15,00 56,75 -98.064 555.526
2018-03-21 2018-03-20 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3.437 11.517 42,54
2018-03-09 2018-03-07 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -2.500 7.500 -25,00
2018-03-09 2018-03-07 4 CLVS Clovis Oncology, Inc.
Common Stock
F - Taxes -1.260 8.080 -13,49 58,43 -73.622 472.114
2018-03-09 2018-03-07 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 2.500 9.340 36,55
2018-03-02 2018-03-01 4 CLVS Clovis Oncology, Inc.
Stock Option (right to buy)
A - Award 11.000 11.000
2018-03-02 2018-03-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
A - Award 11.000 11.000
2017-12-21 2017-12-20 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -13.750 41.250 -25,00
2017-12-21 2017-12-20 4 CLVS Clovis Oncology, Inc.
Common Stock
F - Taxes -6.910 6.840 -50,25 63,80 -440.858 436.392
2017-12-21 2017-12-20 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 13.750 13.750
2017-03-28 2017-03-27 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
A - Award 10.000 10.000
2017-03-28 2017-03-27 4 CLVS Clovis Oncology, Inc.
Stock Option (right to buy)
A - Award 20.000 20.000
2016-12-19 2016-12-19 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
A - Award 55.000 55.000
2015-10-30 2015-10-28 4 CLVS Clovis Oncology, Inc.
Employee stock option (right to buy)
M - Exercise -4.000 23.034 -14,80
2015-10-30 2015-10-28 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -238 0 -100,00 99,22 -23.614
2015-10-30 2015-10-28 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1.962 238 -89,18 98,91 -194.054 23.540
2015-10-30 2015-10-28 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1.300 2.200 -37,14 97,31 -126.507 214.089
2015-10-30 2015-10-28 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -500 3.500 -12,50 95,78 -47.890 335.226
2015-10-30 2015-10-28 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 4.000 4.000 3,08 12.320 12.320
2015-10-07 2015-10-05 4 CLVS Clovis Oncology, Inc.
Employee stock option (right to buy)
M - Exercise -4.000 27.034 -12,89
2015-10-07 2015-10-05 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -322 0 -100,00 96,13 -30.953
2015-10-07 2015-10-05 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -400 322 -55,40 93,92 -37.570 30.244
2015-10-07 2015-10-05 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2.221 722 -75,47 93,01 -206.566 67.150
2015-10-07 2015-10-05 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1.057 2.943 -26,42 91,84 -97.071 270.273
2015-10-07 2015-10-05 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 4.000 4.000 3,08 12.320 12.320
P
Acquisto sul mercato aperto o privato di un titolo non derivato o derivato
S
Vendita sul mercato aperto o privato di un titolo non derivato o derivato
A
Concessione, assegnazione o altra acquisizione di titoli dall'azienda (ad esempio un'opzione)
C
Conversione di un derivato
D
Vendita o trasferimento di titoli alla società
F
Pagamento del prezzo di esercizio o del debito fiscale con la quota di titoli ricevuta dalla società
G
Regalo di titoli da parte o a favore dell'insider
K
Equity swap e operazioni di copertura analoghe
M
Esercizio o conversione di un titolo derivato ricevuto dall'azienda (ad esempio un'opzione)
V
Una transazione dichiarata volontariamente sul modulo 4
J
Altro (accompagnato da una nota a piè di pagina che descriva l'operazione)